Lung eicosanoids in perinatal rats with congenital diaphragmatic hernia
1997

Lung Eicosanoids in Perinatal Rats with Congenital Diaphragmatic Hernia

Sample size: 18 publication Evidence: moderate

Author Information

Author(s): H. IJsselstijn, F. J. Zijlstra, J. P. M. van Dijk, J. C. de Jongste, D. Tibboel

Primary Institution: Erasmus University Rotterdam and University Hospital/Sophia Children's Hospital

Hypothesis

A dysbalance of vasoconstrictive and vasodilatory eicosanoids is involved in persistent pulmonary hypertension in congenital diaphragmatic hernia patients.

Conclusion

Abnormal lung eicosanoid levels are present perinatally in congenital diaphragmatic hernia, with elevated levels of 6-keto-PGF1a possibly reflecting a compensation mechanism for increased vascular resistance.

Supporting Evidence

  • CDH pups showed respiratory insufficiency directly after birth.
  • Control pups had significantly lower lung weights than CDH pups.
  • 6-keto-PGF1a levels were significantly higher in CDH pups compared to controls.

Takeaway

The study found that baby rats with a specific lung condition had higher levels of certain substances that help control blood flow in the lungs, which might be their way of coping with breathing problems.

Methodology

The study measured eicosanoid levels in lung homogenates and bronchoalveolar lavage fluid of control and CDH rats after different delivery methods.

Limitations

The study was limited to a specific animal model and may not fully represent human conditions.

Participant Demographics

Female Sprague-Dawley rats were used in the study.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication